Morgan Stanley’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.65M | Buy |
3,494,292
+200,757
| +6% | +$440K | ﹤0.01% | 3698 |
|
|
2025
Q1 | $4.48M | Sell |
3,293,535
-37,005
| -1% | -$50.3K | ﹤0.01% | 4017 |
|
|
2024
Q4 | $4.43M | Buy |
3,330,540
+292,374
| +10% | +$389K | ﹤0.01% | 4098 |
|
|
2024
Q3 | $3.52M | Buy |
3,038,166
+319,324
| +12% | +$370K | ﹤0.01% | 4232 |
|
|
2024
Q2 | $3.62M | Buy |
2,718,842
+50,899
| +2% | +$67.7K | ﹤0.01% | 4147 |
|
|
2024
Q1 | $5.26M | Sell |
2,667,943
-3,625,219
| -58% | -$7.14M | ﹤0.01% | 3879 |
|
|
2023
Q4 | $8.87M | Buy |
6,293,162
+3,749,268
| +147% | +$5.29M | ﹤0.01% | 4011 |
|
|
2023
Q3 | $3.28M | Buy |
2,543,894
+429,457
| +20% | +$554K | ﹤0.01% | 4041 |
|
|
2023
Q2 | $3.64M | Sell |
2,114,437
-221,858
| -9% | -$382K | ﹤0.01% | 3994 |
|
|
2023
Q1 | $4.23M | Sell |
2,336,295
-78,740
| -3% | -$143K | ﹤0.01% | 3914 |
|
|
2022
Q4 | $6.42M | Buy |
2,415,035
+72,601
| +3% | +$193K | ﹤0.01% | 3513 |
|
|
2022
Q3 | $7.75M | Buy |
2,342,434
+189,366
| +9% | +$627K | ﹤0.01% | 3233 |
|
|
2022
Q2 | $7.84M | Buy |
2,153,068
+358,097
| +20% | +$1.3M | ﹤0.01% | 3326 |
|
|
2022
Q1 | $9.14M | Buy |
1,794,971
+22,886
| +1% | +$116K | ﹤0.01% | 3004 |
|
|
2021
Q4 | $13.5M | Buy |
1,772,085
+789,225
| +80% | +$6.02M | ﹤0.01% | 2586 |
|
|
2021
Q3 | $14.5M | Sell |
982,860
-40,629
| -4% | -$601K | ﹤0.01% | 2448 |
|
|
2021
Q2 | $18.9M | Buy |
+1,023,489
| New | +$18.9M | ﹤0.01% | 2212 |
|